RecruitingNCT04354545
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Sponsor
University of California, Los Angeles
Enrollment
75 participants
Start Date
Apr 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Eligibility
Plain Language Summary
Simplified for easier understanding
This study is evaluating a prescription eye drop called Xiidra (lifitegrast) for reducing eye surface discomfort in glaucoma patients who use multiple eye drops to control their eye pressure. Long-term use of glaucoma drops can irritate the surface of the eye, and Xiidra may help relieve that discomfort.
**You may be eligible if:**
- You are currently using one or more topical glaucoma eye drops to lower eye pressure
- You experience symptoms of eye surface discomfort (dryness, irritation, etc.)
- Xiidra has been prescribed as part of your standard glaucoma care
**You may NOT be eligible if:**
- You have had glaucoma filtering surgery or eye surface surgery (such as pterygium removal)
- You are currently using topical cyclosporine eye drops
- You are currently using topical steroid eye drops
- You have had eye surgery within the past 6 months
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGXiidra (Lifitegrast ophthalmic solution) 5%
FDA approved lifitegrast opthalmic solution eye drop
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04354545
Related Trials
Dresden Glaucoma and Treatment Study (DGTS)
NCT029592421 location
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT070757183 locations
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
NCT07770685
Functional and Structural Imaging for Glaucoma
NCT019572671 location
Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
NCT062276112 locations